138 related articles for article (PubMed ID: 10499484)
1. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.
Heydorn S; Jeppesen PB; Mortensen PB
Scand J Gastroenterol; 1999 Aug; 34(8):818-23. PubMed ID: 10499484
[TBL] [Abstract][Full Text] [Related]
2. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.
Kapral C; Wewalka F; Praxmarer V; Lenz K; Hofmann AF
Z Gastroenterol; 2004 Jul; 42(7):583-9. PubMed ID: 15248106
[TBL] [Abstract][Full Text] [Related]
3. Conjugated bile acid replacement therapy for short-bowel syndrome.
Gruy-Kapral C; Little KH; Fordtran JS; Meziere TL; Hagey LR; Hofmann AF
Gastroenterology; 1999 Jan; 116(1):15-21. PubMed ID: 9869597
[TBL] [Abstract][Full Text] [Related]
4. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
[TBL] [Abstract][Full Text] [Related]
5. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.
Longmire-Cook SJ; Lillienau J; Kim YS; Schteingart CD; Danzinger RG; Esch O; Hofmann AF
Dig Dis Sci; 1992 Aug; 37(8):1217-27. PubMed ID: 1379904
[TBL] [Abstract][Full Text] [Related]
6. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.
Fürst T; Bott C; Stein J; Dressman JB
J Pharm Pharmacol; 2005 Jan; 57(1):53-60. PubMed ID: 15638993
[TBL] [Abstract][Full Text] [Related]
7. Colon as a digestive organ in patients with short bowel.
Nordgaard I; Hansen BS; Mortensen PB
Lancet; 1994 Feb; 343(8894):373-6. PubMed ID: 7905549
[TBL] [Abstract][Full Text] [Related]
8. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection.
Jeppesen PB; Mortensen PB
Gut; 1998 Oct; 43(4):478-83. PubMed ID: 9824573
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.
Lillienau J; Schteingart CD; Hofmann AF
J Clin Invest; 1992 Feb; 89(2):420-31. PubMed ID: 1371123
[TBL] [Abstract][Full Text] [Related]
10. Importance of colonic support for energy absorption as small-bowel failure proceeds.
Nordgaard I; Hansen BS; Mortensen PB
Am J Clin Nutr; 1996 Aug; 64(2):222-31. PubMed ID: 8694024
[TBL] [Abstract][Full Text] [Related]
11. Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation.
Schmassmann A; Angellotti MA; Ton-Nu HT; Schteingart CD; Marcus SN; Rossi SS; Hofmann AF
Gastroenterology; 1990 Jan; 98(1):163-74. PubMed ID: 1688373
[TBL] [Abstract][Full Text] [Related]
12. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
13. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF
Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
[TBL] [Abstract][Full Text] [Related]
15. Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure.
Jeppesen PB; Mortensen PB
JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S101-5. PubMed ID: 10483907
[TBL] [Abstract][Full Text] [Related]
16. Energy intake in short bowel syndrome: assessment by 24-h dietary recalls compared with the doubly labelled water method.
Fassini PG; Das SK; Pfrimer K; Suen VMM; Sérgio Marchini J; Ferriolli E
Br J Nutr; 2018 Jan; 119(2):196-201. PubMed ID: 29268807
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study.
Jeppesen PB; Szkudlarek J; Høy CE; Mortensen PB
Scand J Gastroenterol; 2001 Jan; 36(1):48-54. PubMed ID: 11218239
[TBL] [Abstract][Full Text] [Related]
18. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine.
Michael S; Thöle M; Dillmann R; Fahr A; Drewe J; Fricker G
Eur J Pharm Sci; 2000 Apr; 10(2):133-40. PubMed ID: 10727879
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of faecal fatty acid excretion in short bowel syndrome in newborns.
Heineman E; Dejong CH; Piena-Spoel M; Liefaard G; Molenaar JC; Tibboel D
J Pediatr Surg; 1996 Apr; 31(4):520-5. PubMed ID: 8801304
[TBL] [Abstract][Full Text] [Related]
20. [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.
Frisch K; Jakobsen S; Sørensen M; Munk OL; Alstrup AK; Ott P; Hofmann AF; Keiding S
J Nucl Med; 2012 May; 53(5):772-8. PubMed ID: 22454486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
